Original Research
Published on 18 Feb 2020
Combination of Ruthenium Complex and Doxorubicin Synergistically Inhibits Cancer Cell Growth by Down-Regulating PI3K/AKT Signaling Pathway
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2020.00141
- 6,612 views
- 38 citations


